The newly licensed platform enables precise control over both the drug-to-antibody ratio and payload attachment sites in single- and dual-payload ADCs
Growth driven by strong performance across Sugar Free, RiteBite Max Protein, Everyuth, Glucon-D and Nutralite portfolios
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
Drugmaker taps 1 million retail touchpoints, quick commerce and modern trade to expand ingredient-led skincare franchise
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
KeyCi’s dermatologically tested lineup emphasizes clean formulations—vegan, cruelty-free, alcohol-free, and paraben-free—while being backed by pharmaceutical-grade research and FDA approval
Our clinical data suggests ProLectin-M demonstrated earlier reductions in viral shedding compared with placebo with a favorable safety profile
Expansion at the Oss (NL) site adds capacity and R&D capabilities, supporting the development and manufacturing of ADCs and other novel bioconjugates from First-in-Human to commercialization
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
